Clozapine is the only antipsychotic approved by the Food and Drug Administration (FDA) for
treatment-resistant schizophrenia (TRS)(Kane et al 1988). It is also approved for suicidality …

Abstract Using Richardson and Davidson's model and the sciences of pharmacokinetics and
clinical pharmacopsychology, this article reviewed the:(1) poor life expectancy associated …

The ongoing coronavirus disease 2019 (COVID-19) pandemic is posing multiple
unprecedented challenges to psychiatrists all over the world. So far, there is no data on …

Clozapine is a highly potent atypical antipsychotic popularly used for treating refractory
schizophrenia. Clozapine displays a complex mechanism of action. There are emerging …

We would like to describe a case of clozapine intoxication as a result of COVID-19 infection.
As far as we are aware, an example of this has not yet been described. In patients treated …

TO THE EDITOR: The COVID-19 pandemic presents a variety of unique challenges for
psychiatric practice including decreased inperson visits, difficulties obtaining lab work, and …

As COVID-19 pandemic has spread all over the world and patients' number is escalating
(Tandon, 2020), different statutory bodies like Centers for Disease Control (CDC), Govt. of …

Clozapine is a transformative drug and the most effective drug for refractory schizophrenia. It
is a dibenzodiazepine and is a forerunner atypical antipsychotic. Clozapine has recognized …

Background The COVID-19 pandemic prompted the rapid development of vaccines to
combat the virus. Several COVID-19 vaccines have proven effective in preventing infection …